Opiant Pharmaceuticals (OPNT) Short Interest Ratio & Short Volume

Short interest is the volume of Opiant Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 40,900 shares of OPNT short. Learn More on Opiant Pharmaceuticals' current short interest.

Opiant Pharmaceuticals saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 40,900 shares, an increase of 3.8% from the previous total of 39,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Opiant Pharmaceuticals: OptiNose, Inc. (2.76%), Cartesian Therapeutics, Inc. (5.31%), Immunic, Inc. (3.37%), FibroGen, Inc. (5.65%), Eliem Therapeutics, Inc. (0.07%), CytomX Therapeutics, Inc. (4.90%), Seres Therapeutics, Inc. (12.45%), Rezolute, Inc. (0.63%), Clearside Biomedical, Inc. (0.30%), Societal CDMO, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.09 billion), Occidental Petroleum Co. ($3.00 billion), T. Rowe Price Group, Inc. ($2.35 billion), Coinbase Global, Inc. ($2.30 billion), Paramount Global ($2.04 billion), Etsy, Inc. ($1.90 billion), Voya Financial, Inc. ($1.77 billion), CarMax, Inc. ($1.67 billion), Royal Caribbean Cruises Ltd. ($1.58 billion), and Monolithic Power Systems, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling OPNT is an investing strategy that aims to generate trading profit from Opiant Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Opiant Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPNT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPNT, twice per month. The most recent reporting period available is February, 15 2023.